These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35915922)

  • 1. German Diabetes Risk Score for the Determination of the Individual Type 2 Diabetes Risk.
    Schiborn C; Paprott R; Heidemann C; Kühn T; Fritsche A; Kaaks R; Schulze MB
    Dtsch Arztebl Int; 2022 Sep; 119(39):651-657. PubMed ID: 35915922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and external validation of a clinical version of the German Diabetes Risk Score (GDRS) including measures of HbA1c.
    Mühlenbruch K; Paprott R; Joost HG; Boeing H; Heidemann C; Schulze MB
    BMJ Open Diabetes Res Care; 2018; 6(1):e000524. PubMed ID: 30002858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study.
    Mühlenbruch K; Ludwig T; Jeppesen C; Joost HG; Rathmann W; Meisinger C; Peters A; Boeing H; Thorand B; Schulze MB
    Diabetes Res Clin Pract; 2014 Jun; 104(3):459-66. PubMed ID: 24742930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A newly developed and externally validated non-clinical score accurately predicts 10-year cardiovascular disease risk in the general adult population.
    Schiborn C; Kühn T; Mühlenbruch K; Kuxhaus O; Weikert C; Fritsche A; Kaaks R; Schulze MB
    Sci Rep; 2021 Oct; 11(1):19609. PubMed ID: 34608230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes.
    Schulze MB; Hoffmann K; Boeing H; Linseisen J; Rohrmann S; Möhlig M; Pfeiffer AF; Spranger J; Thamer C; Häring HU; Fritsche A; Joost HG
    Diabetes Care; 2007 Mar; 30(3):510-5. PubMed ID: 17327313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the German Diabetes Risk Score within a population-based representative cohort.
    Hartwig S; Kuss O; Tiller D; Greiser KH; Schulze MB; Dierkes J; Werdan K; Haerting J; Kluttig A
    Diabet Med; 2013 Sep; 30(9):1047-53. PubMed ID: 23586438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of type 2 diabetes mellitus onset using logistic regression-based scorecards.
    Edlitz Y; Segal E
    Elife; 2022 Jun; 11():. PubMed ID: 35731045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study.
    Abbasi A; Peelen LM; Corpeleijn E; van der Schouw YT; Stolk RP; Spijkerman AM; van der A DL; Moons KG; Navis G; Bakker SJ; Beulens JW
    BMJ; 2012 Sep; 345():e5900. PubMed ID: 22990994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
    Xu S; Coleman RL; Wan Q; Gu Y; Meng G; Song K; Shi Z; Xie Q; Tuomilehto J; Holman RR; Niu K; Tong N
    Cardiovasc Diabetol; 2022 Sep; 21(1):182. PubMed ID: 36100925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Validation of the German Diabetes Risk Score with metabolic risk factors for type 2 diabetes].
    Schulze MB; Boeing H; Häring HU; Fritsche A; Joost HG
    Dtsch Med Wochenschr; 2008 Apr; 133(17):878-83. PubMed ID: 18415912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma
    Wittenbecher C; Štambuk T; Kuxhaus O; Rudman N; Vučković F; Štambuk J; Schiborn C; Rahelić D; Dietrich S; Gornik O; Perola M; Boeing H; Schulze MB; Lauc G
    Diabetes Care; 2020 Mar; 43(3):661-668. PubMed ID: 31915204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.
    Cai X; Zhu Q; Cao Y; Liu S; Wang M; Wu T; Hong J; Ahmat A; Aierken X; Li N
    Biomed Res Int; 2021; 2021():5527460. PubMed ID: 34095297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort.
    Heidemann C; Boeing H; Pischon T; Nöthlings U; Joost HG; Schulze MB
    Eur J Epidemiol; 2009; 24(6):281-8. PubMed ID: 19357973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.
    Spranger J; Kroke A; Möhlig M; Hoffmann K; Bergmann MM; Ristow M; Boeing H; Pfeiffer AF
    Diabetes; 2003 Mar; 52(3):812-7. PubMed ID: 12606524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up procedures in EPIC-Germany--data quality aspects. European Prospective Investigation into Cancer and Nutrition.
    Bergmann MM; Bussas U; Boeing H
    Ann Nutr Metab; 1999; 43(4):225-34. PubMed ID: 10592371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study.
    Iqbal K; Schwingshackl L; Floegel A; Schwedhelm C; Stelmach-Mardas M; Wittenbecher C; Galbete C; Knüppel S; Schulze MB; Boeing H
    Eur J Nutr; 2019 Jun; 58(4):1673-1686. PubMed ID: 29761319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear regression calibration: theoretical framework and empirical results in EPIC, Germany.
    Kynast-Wolf G; Becker N; Kroke A; Brandstetter BR; Wahrendorf J; Boeing H
    Ann Nutr Metab; 2002; 46(1):2-8. PubMed ID: 11914509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the CHARGE-AF risk model for incident atrial fibrillation in the EPIC Norfolk cohort.
    Pfister R; Brägelmann J; Michels G; Wareham NJ; Luben R; Khaw KT
    Eur J Prev Cardiol; 2015 Jul; 22(7):932-9. PubMed ID: 25059930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.
    Schienkiewitz A; Schulze MB; Hoffmann K; Kroke A; Boeing H
    Am J Clin Nutr; 2006 Aug; 84(2):427-33. PubMed ID: 16895894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.